In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

The U.S. Centers for Medicare & Medicaid Services posted the draft home health rule for calendar year 2026, which includes a proposal to subject continuous glucose monitors and insulin pumps to ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

Disclosures Diabetes Care. 2015;38 (4):716-722. Summary By harnessing innovative technology, modern insulin pumps appear to provide clinically important and increasing benefits for people with ...

The t:slim X2 insulin pump is powered by Control-IQ+ technology, the latest generation of Tandem's advanced hybrid closed-loop algorithm, which adjusts insulin every 5 minutes based on predicted ...

The Niia Essential insulin patch pump. [Image from PharmaSens on LinkedIn] PharmaSens today announced a strategic partnership with SiBionics to jointly develop an all-in-one insulin patch pump.

Investing.com -- Truist Securities launched coverage on four diabetes technology companies, saying there is a long-term growth potential for continuous glucose monitors (CGM) and insulin pumps amid ...

They announced the integration of FreeStyle Libre 2 Plus CGM into the t:slim X2 insulin pump in January 2024. “Integrating our advanced insulin delivery systems with Abbott’s future glucose-ketone ...